Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone treatment in children born small for gestational age with persistent short stature
NL-OMON27215Active, not recruiting
- Sponsor
- Erasmus MC Sophia Children's Hospital
- Start
- Dec 1996
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of somatropin in Small for gestational age (SGA) and growth hormone deficiency (GHD) (4 arms), sponsored by Erasmus MC Sophia Children's Hospital. Primary endpoint: Primary efficacy endpoint. Started Dec 1996; status: active, not recruiting.
02
Drugs
somatropin
03
Conditions
Small for gestational age (SGA)growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NL-OMON27215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27215.